Detalles de la búsqueda
1.
ARRB2 promotes colorectal cancer growth through triggering WTAP.
Acta Biochim Biophys Sin (Shanghai)
; 53(1): 85-93, 2021 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367479
2.
Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/ß-catenin signalling activation.
J Cell Biochem
; 120(10): 16934-16945, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104336
3.
miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.
Lab Invest
; 99(10): 1484-1500, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31201367
4.
Knockout of NCOA5 impairs proliferation and migration of hepatocellular carcinoma cells by suppressing epithelial-to-mesenchymal transition.
Biochem Biophys Res Commun
; 500(2): 177-183, 2018 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29626478
5.
LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Int J Hyperthermia
; 34(6): 802-811, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29295626
6.
TIMELESS contributes to the progression of breast cancer through activation of MYC.
Breast Cancer Res
; 19(1): 53, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464854
7.
MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
Mol Cancer
; 16(1): 122, 2017 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28716024
8.
NCOA5 is correlated with progression and prognosis in luminal breast cancer.
Biochem Biophys Res Commun
; 482(2): 253-256, 2017 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847318
9.
Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Mol Cancer
; 15: 17, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26896959
10.
MLF1IP is correlated with progression and prognosis in luminal breast cancer.
Biochem Biophys Res Commun
; 477(4): 923-926, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27378428
11.
Direct interaction between miR-203 and ZEB2 suppresses epithelial-mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance.
Acta Biochim Biophys Sin (Shanghai)
; 48(11): 1042-1049, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27733346
12.
The pretreatment albumin to globulin ratio, a validated biomarker, predicts prognosis in hepatocellular carcinoma.
J BUON
; 21(4): 925-934, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27685915
13.
Clinical and pathological response to neoadjuvant chemotherapy based on primary tumor reduction is correlated to survival in hormone receptor-positive but not hormone receptor-negative locally advanced breast cancer.
Ann Surg Oncol
; 22(1): 32-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25012266
14.
Predictive value of microtubule-associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane-containing palliative chemotherapy.
Tumour Biol
; 36(5): 3941-7, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773385
15.
Small interfering RNA (siRNA)-mediated knockdown of Notch1 suppresses tumor growth and enhances the effect of IL-2 immunotherapy in malignant melanoma.
J BUON
; 20(6): 1553-64, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26854453
16.
TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3ß pathway.
Tumour Biol
; 35(9): 8969-77, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24903376
17.
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.
BMC Genet
; 15: 67, 2014 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-24919593
18.
Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer.
World J Surg Oncol
; 12: 378, 2014 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25487539
19.
The true role of mRECIST guideline: does it really estimate viable tumor or merely improve accuracy in hepatocellular carcinoma response evaluation?
J BUON
; 19(2): 398-405, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24965398
20.
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.
Lancet Oncol
; 14(10): 953-61, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23948351